Impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococci. [electronic resource]
Producer: 20160321Description: 3968-75 p. digitalISSN:- 1098-6596
- Adult
- Aged
- Aged, 80 and over
- Anti-Bacterial Agents -- economics
- Bacteremia -- drug therapy
- Cohort Studies
- Daptomycin -- economics
- Female
- Gram-Positive Bacterial Infections -- drug therapy
- Hospital Costs
- Humans
- Linezolid -- economics
- Male
- Microbial Sensitivity Tests
- Middle Aged
- Severity of Illness Index
- Vancomycin Resistance -- drug effects
- Vancomycin-Resistant Enterococci -- drug effects
- beta-Lactams -- economics
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.